Currently, there is a paucity of highly specific and sensitive markers to identify breast
carcinoma in male patients. Immunohistochemical stains commonly used for unmasking …

Context.—Definitive diagnosis of metastatic triple-negative breast carcinoma (TNBC) is
challenging on cytologic samples. Recent studies demonstrated that trichorhinophalangeal …

Objectives Recent studies have shown that trichorhinophalangeal syndrome type 1 (TRPS1)
is a sensitive and specific marker that shows positive staining in breast carcinoma. We …

Background Trichorhinophalangeal syndrome type 1 (TRPS1) is a novel
immunohistochemical marker with excellent performance in distinguishing breast carcinoma …

Abstract Trichorhinophalangeal syndrome type 1 (TRPS1) has been reported to be a
sensitive and specific immunohistochemical (IHC) marker for breast carcinomas, especially …

Abstract Trichorhinophalangeal syndrome type 1 (TRPS1) is a new reportedly sensitive and
specific immunohistochemical marker for carcinomas of breast origin, including triple …

Abstract Trichorhinophalangeal syndrome 1 (TRPS1) is a nuclear protein highly expressed
in breast epithelial cells. TRPS1 immunohistochemistry (IHC) has been suggested as a …

Currently there is no highly specific and sensitive marker to identify breast cancer—the most
common malignancy in women. Breast cancer can be categorized as estrogen receptor …

Aims Trichorhinophalangeal syndrome‐1 (TRPS1) has been proposed as a novel breast
marker with equally high expression in breast cancer (BC) subtypes, making it a useful …

Background Although trichorhinophalangeal syndrome type 1 (TRPS1) was initially thought
to be highly sensitive and specific for carcinomas and mesenchymal tumors of mammary …